methoxy-morpholinyl-doxorubicin and Nausea

methoxy-morpholinyl-doxorubicin has been researched along with Nausea in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bakker, M; de Vries, EG; Domenigoni, L; Droz, JP; Groen, HJ; Hanauske, AR; Pacciarini, MA; Pianezzola, E; van Oosterom, AT; van Weissenbruch, F; Verweij, J	1

Trials

1 trial(s) available for methoxy-morpholinyl-doxorubicin and Nausea

Article	Year
Broad phase II and pharmacokinetic study of methoxy-morpholino doxorubicin (FCE 23762-MMRDX) in non-small-cell lung cancer, renal cancer and other solid tumour patients. British journal of cancer, 1998, Volume: 77, Issue:1 Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Doxorubicin; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Middle Aged; Nausea; Neutropenia; Thrombocytopenia; Treatment Outcome	1998

Article

Year

Broad phase II and pharmacokinetic study of methoxy-morpholino doxorubicin (FCE 23762-MMRDX) in non-small-cell lung cancer, renal cancer and other solid tumour patients.

British journal of cancer, 1998, Volume: 77, Issue:1

Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Doxorubicin; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Middle Aged; Nausea; Neutropenia; Thrombocytopenia; Treatment Outcome

1998